Skip to main content
Premium Trial:

Request an Annual Quote

Dx Focus: Roche's Cobas AmpliPrep/Cobas TaqMan HCV Test v2.0

Premium

Roche said this week that it has received approval from the US Food and Drug Administration for its Cobas AmpliPrep/Cobas TaqMan HCV Test, v2.0.

Roche's assay is designed to help manage patients with chronic hepatitis C virus infection, in conjunction with clinical and laboratory markers of infection. The test quantifies hepatitis C virus RNA genotypes 1 to 6 in human EDTA plasma or serum, and can be used to predict the probability of sustained virologic response early during a course of antiviral therapy and to assess viral response to antiviral treatment, as measured by changes of HCV RNA levels.

The real-time PCR-based assay is designed for use on Roche's fully automated Cobas AmpliPrep/Cobas TaqMan System, a platform for viral load monitoring of multiple infectious diseases. The system can be combined with the Cobas p 630 instrument, which provides an integrated pre-analytical primary tube handling solution.

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.